EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm

Cody Eslinger iD, Mohamad Bassam Sonbol iD, Ben George, Hani Babiker, Mitesh J Borad, Tanios S Bekaii-Saab

Drug Design, Development and Therapy · 2026-03 · Volume 20 · 1-15

DOI: 10.2147/dddt.s559325 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-03. Verfasst von Cody Eslinger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Proto-Oncogene Proteins p21(ras), Antineoplastic Agents, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsProto-Oncogene Proteins p21(ras)Antineoplastic AgentsCarcinoma, Pancreatic DuctalHumansMolecular Targeted TherapyAnimalsMutation

Stichwörter der Autor:innen

KRASchemotherapynext generation sequencingpancreatic cancertargeted therapy

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Department of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA.

ORCID-Profile: Cody Eslinger, Mohamad Bassam Sonbol

Zitieren

APA

Eslinger, C., Sonbol, M. B., George, B., Babiker, H., Borad, M. J., & Bekaii-Saab, T. S. (2026). Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm. Drug Design, Development and Therapy, Volume 20, 1-15. https://doi.org/10.2147/dddt.s559325

Vancouver

Eslinger C, Sonbol MB, George B, Babiker H, Borad MJ, Bekaii-Saab TS. Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm. Drug Design, Development and Therapy. 2026;Volume 20:1-15. doi:10.2147/dddt.s559325

BibTeX
@article{Eslinger2026,
  author = {Eslinger, Cody and Sonbol, Mohamad Bassam and George, Ben and Babiker, Hani and Borad, Mitesh J and Bekaii-Saab, Tanios S},
  title = {Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--15},
  doi = {10.2147/dddt.s559325}
}
Kostenlos starten →